(Q43486713)

English

Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients

scientific article published in July 2005

In more languages
default for all languages
No label defined

No description defined

Statements

Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients (English)
Clotilde Allavena
Cécile Brunet-François
Jean-François Delfraissy
Alain Lafeuillade
Marc-Antoine Valantin
Michelle Bentata
Christian Michelet
Bitherapy Kaletra-Sustiva Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit